Cover Image

Pharmacological guidelines for managing temporomandibular disorders

Temporomandibular disorders (TMD) characterize a heterogeneous group of conditions involving the temporomandibular joint (TMJ) and its contiguous tissues. Although the etiology and pathophysiology underlying the development of TMD have not been completely explained, the symptoms associated with thes...

Full description

Saved in:
Bibliographic Details
Main Authors: Eduardo Dias de Andrade Eduardo Dias de Andrade (Author), Célia Maria Rizzatti-Barbosa (Author), Marcos Luciano Pimenta Pinheiro (Author)
Format: Book
Published: Universidade Estadual de Campinas, 2015-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Temporomandibular disorders (TMD) characterize a heterogeneous group of conditions involving the temporomandibular joint (TMJ) and its contiguous tissues. Although the etiology and pathophysiology underlying the development of TMD have not been completely explained, the symptoms associated with these disorders are similar and are most commonly manifested as pain in the orofacial region. Despite the large body of literature on therapeutic modalities for TMD, this article briefly discusses the most common and current pharmacological clinical guidelines for managing TMD.
Item Description:10.20396/bjos.v3i10.8641761
1677-3225

Similar Items